featured
Advances in CDK 4/6 Inhibitor Use For Metastatic Breast Cancer From ESMO 2017
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: